Skip to main content

Editorial Board

Editor-in-Chief
Scott K Durum, National Cancer Institute, NIH, USA

Senior Editor
Cristina Bergamaschi, National Cancer Institute, NIH, USA

Editorial Board Members
David Artis, Cornell University, USA
Rachel Caspi, National Eye Institute, NIH, USA
Fabio Cominelli, Case Western Reserve University, USA
James Di Santo, Institut Pasteur, France
Charles Dinarello, University of Colorado, USA
Chen Dong, Tsinghua University, China
Gordon Duff, University of Oxford, UK
Eleanor Fish, University of Toronto, Canada
Sarah Gaffen, University of Pittsburgh, USA
Ana Gamero, Temple University, USA
Christopher Hunter, University of Pennsylvania, USA
Simon Jones, Cardiff University, UK
Carl June, University of Pennsylvania, USA
Annette Khaled, Burnett School of Biomedical Sciences, USA
Alberto Mantovani, Humanitas University, Italy
Philip M Murphy, NIAID, NIH, USA
Sandra Nicholson, Walter and Eliza Hall Institute of Medical Research, Australia
Luke O’Neill, Trinity College Dublin, Ireland
John O’Shea, NIAMS, NIH, USA
Keiko Ozato, NICHD, NIH, USA
Chung-Gyu Park, Seoul National University College of Medicine, South Korea
Nancy Reich, Stony Brook School of Medicine, USA
Charles Samuel, UC Santa Barbara, USA
Ram Savan, University of Washington, USA
Kimberly Schluns, MD Anderson Cancer Center, USA
Richard Siegel, NIAID, NIH,  USA
Tadatsugu Taniguchi, University of Tokyo, Japan
Jennifer Towne, The Janssen Pharmaceutical Companies, USA
Marcel Van den Brink, Memorial Sloan Kettering Cancer Center, USA
Scott Walsh, National Cancer Institute, NIH  USA
Bryan Williams, Hudson Institute of Medical Research, Australia